Clinical Utility of Non-Invasive Prenatal Screening from Maternal Blood
- PMID: 28465744
- PMCID: PMC5394445
Clinical Utility of Non-Invasive Prenatal Screening from Maternal Blood
Similar articles
-
Prenatal screening for fetal aneuploidy in singleton pregnancies.J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1. J Obstet Gynaecol Can. 2011. PMID: 21749752
-
No. 261-Prenatal Screening for Fetal Aneuploidy in Singleton Pregnancies.J Obstet Gynaecol Can. 2017 Sep;39(9):e380-e394. doi: 10.1016/j.jogc.2017.06.013. J Obstet Gynaecol Can. 2017. PMID: 28859781
-
Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.J Obstet Gynaecol Can. 2011 Jul;33(7):754-67. J Obstet Gynaecol Can. 2011. PMID: 21749753
-
Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood.J Obstet Gynaecol Res. 2007 Dec;33(6):747-64. doi: 10.1111/j.1447-0756.2007.00652.x. J Obstet Gynaecol Res. 2007. PMID: 18001438 Review.
-
Fetal cells in maternal blood: state of the art for non-invasive prenatal diagnosis.Ann Acad Med Singap. 2003 Sep;32(5):597-603; quiz 604. Ann Acad Med Singap. 2003. PMID: 14626786 Review.
References
-
- Hook EB, Cross PK, Schreinemachers DM - Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA. 1983;249:2034. - PubMed
-
- Haraldsdottir KR, Gottfredsdottir H, Geirsson RT - CarcinomaFetal loss after amniocentesis and chorionic villus sampling in Iceland. Laeknabladid. 2014;100:147–151. - PubMed
-
- Nicolaides KH - Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn. 2011;31:7–15. - PubMed
-
- Bischoff FZ, Lewis DE, Simpson JL - Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum Reprod Update. 2005;11:59–67. - PubMed
-
- Lo YM, Corbetta N, Chamberlain PF, et al. - Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;16:350–485. - PubMed
LinkOut - more resources
Full Text Sources